CHI3L1 and juvenile Huntington disease: Reportedly, Chi3l1 is significantly increased and a promising biomarker for multiple neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), dementia, and amyotrophic lateral sclerosis (ALS) (Figure 1).